Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116.

Slides:



Advertisements
Similar presentations
Supplemental Figure 1 A No. at risk T T T
Advertisements

Tfam 1  g empty vector 1  g Tfb2m 1  g Relative mRNA level * * p
Figure S1 A P
Figure 1 HuR Tis11b HPRT VEGF Time (h) A 462 bp (VEGF 165 ) 332 bp (VEGF 121 ) 354 bp 111 bp 305 bp.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.
Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.
Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.
Supplemental Figure S1: Diagram to show previously reported interactions between EGFR and 23 other Egr1 target genes using Pathway Studio, Ariadne Inc.
Supplementary Figure 1A-B A H1299 RH LC3-I / II P-GSK-3 (Ser21/9) GSK-3α/β β-actin β-catenine P-GSK-3 (Tyr279/216) B.
Supplementary Figure 1. Suzuki et al. DAPI/BrdU BrdU 24 hrs 48 hrs 72 hrs.
Supplemental Table 1 Source and authentication of cell lines.
Figure S UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *
Supplemental Figure S1 A B MDA-MB-231 MCF-7 BCL-2MDA-MB-231 BCL-2 MCF-7 Bcl-2 Actin Bcl-2 Actin.
Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V A B C ANXA1.
Supplementary Figure S1 a
Supplementary Figure S4
Progesterone receptor
Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.
ABAE positive cells 6h after treatment
Supplementary Figure 1 (log fold change relative to untreated control)
Induction of mPer1 mRNA expression by prostaglandin E2 (PGE2) in NIH3T3 cells. Induction of mPer1 mRNA expression by prostaglandin E2 (PGE2) in NIH3T3.
MCF-7: E2 E2(-4h)+OHT E2(-4h)+ICI (h)
a b p= 0,2 0,4 0,6 0,8 1 1,2 BCL11A * Relativeexpression 0,2 0,4 0,6
miR-133a positively regulated p53/p21 pathway.
Supplementary figure S1 by Shin et al.
Supplementary Figure 1 A B C siControl siRNF31 siRNF31+siP53 siControl
A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC
The mRNA stem cell signature.
Supplementary Figure S1
Days after cell inoculation Days after cell inoculation
UVC UVB A B Supplementary 1, Borrelli et al.
Identification of genes associated with a gain of prion susceptibility Increased susceptibilities of revertant cell clones R2, R5 and R7 after retinoic.
Treatment EPO (1 IU/ml) Placebo
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Lutz et al, Neuropsychopharmacology
8 slides for 4 panels (A-D)
Supplemental Figure 1A Pt Pt Pre-treatment
TSA dose-dependent increase in transcription.
Figure 9.1.
Supplementary Figure 1. A
UV Induces p21WAF1/CIP1 Protein in Keratinocytes Without p53
Figure S4 control-siRNA Day 0 fes A-siRNA Day 3 fer 1-siRNA
Validation of p53- and miRNA-mediated down-regulation
Bernard et al, Supplementary Figure S1
Supplementary Figure S4
Chemotherapeutic Drug Combination Index Description
Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc
20S proteasome activities
TSA induces transcription from CCND1-MS2 alleles under CCND1 promoter control. TSA induces transcription from CCND1-MS2 alleles under CCND1 promoter control.
TWEAK downregulates SIRT3 in cultured tubular cells and this is prevented by crotonate. TWEAK downregulates SIRT3 in cultured tubular cells and this is.
SYCE2 induces resistance to ionizing radiation and cisplatin in somatic cells. SYCE2 induces resistance to ionizing radiation and cisplatin in somatic.
SIRT1 is downregulated in human gastric cancer (GC).
Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.
CREB1 promotes the induction of endogenous ERα target genes.
MW (kDa) 2 µg 0.5 µg Supplementary Figure S1. SDS-PAGE under reducing condition analysis (Coomassie brilliant blue staining) of.
Induction of apoptosis by NMT siRNAs.
Depletion of HDAC2 sensitizes cells to epirubicin-induced apoptosis.
Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.
IGF-IR in human head and neck cancer.
A and B, comparison of time course of TFF1 mRNA induction under estrogen-withdrawn (denoted ph−/ES−) and estrogenic medium (denoted ph+/ES+) conditions.
Fig. 3. KMS99220 inhibits activation of NFκB signaling via HO-1 induction. (A) BV2 cells were treated with 10 µM KMS99220 for 1 h, and then treated with.
Bortezomib induces an NRF2 signature and NRF2 protein in tumor cells from leukemic MCL. Gene sets regulated by bortezomib (Supplementary Tables S3 and.
EGFR signaling regulates transcription of PDGFRβ gene.
LRP1 is necessary for rK5-induced apoptosis of primary human brain MvEC. LRP1 is necessary for rK5-induced apoptosis of primary human brain MvEC. Irradiated.
CHL-induced apoptosis in HCT116 cells involves the activation of procaspase-8 and procaspase-6, with cleavage of nuclear lamins. CHL-induced apoptosis.
Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3 S284 through MDM2. Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3.
RPL26 is a positive regulator of TP53β splicing.
Validation of MYC-driven drug responses.
Hcy decreases VEGFR1/2 and Angs (Ang1, Ang2) gene transcription
Presentation transcript:

Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE WI MCF10A HCT HCT116 p53 -/ MCF R 2 value0.394

** Knight et al – Supplementary Figure 1 AROS 2 siRNA Mock Fold apoptosis induction SIRT1 siRNA AROS 1 siRNA AB n.s.

Knight et al – Supplementary Figure 2 mRNA expression (%) siRNA HCT116 mRNA expression (%) siRNA HCT116 p53 -/- mRNA expression (%) siRNA MCF7 mRNA expression (%) siRNA WI-38 mRNA expression (%) siRNA MCF10A Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA

Mock SIRT1 AROS siRNA Fold apoptosis vs. Mock *** Etoposide and TSA *** Mock AROS SIRT1 UV-C irradiation Knight et al – Supplementary Figure 3 Condition β-actin K382Ac Treatment p53 Etoposide and TSA UV-CControl * 37kDa 50kDa A B